🇺🇸 FDA
Patent

US 7084151

5-(1',1'-cycloalkyl/alkenyl)methylidene 1,2-dihydro-5H-chromeno[3,4-ƒ]quinolines as selective progesterone receptor modulator compounds

granted A61PA61P13/08A61P15/00

Quick answer

US patent 7084151 (5-(1',1'-cycloalkyl/alkenyl)methylidene 1,2-dihydro-5H-chromeno[3,4-ƒ]quinolines as selective progesterone receptor modulator compounds) held by Ligand Pharmaceuticals Incorporated expires Mon Jul 27 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Ligand Pharmaceuticals Incorporated
Grant date
Tue Aug 01 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 27 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61P, A61P13/08, A61P15/00, A61P15/08, A61P19/00